Tonix Pharmaceuticals Holding (TNXP) Amortization of Deferred Charges (2011 - 2012)
Tonix Pharmaceuticals Holding (TNXP) posted Amortization of Deferred Charges of -$166.0 for Q4 2012, down 100.08% on a QoQ basis from $196166.0 in Q1 2012, and down 100.31% year-over-year from $53377.0 in Q1 2012.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Amortization of Deferred Charges (2011 - 2012) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Amortization of Deferred Charges for 2 years, with the latest figure at -$166.0 in Q4 2012.
- On a quarterly basis, Amortization of Deferred Charges fell 100.31% year-over-year to -$166.0 in Q4 2012; TTM through Sep 2013 was -$166.0, a 100.07% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, changed N/A from the prior year.
- Amortization of Deferred Charges was -$166.0 for Q4 2012 at Tonix Pharmaceuticals Holding, down from $196166.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $196166.0 in Q1 2012, with the low at -$166.0 in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | -166.00 |
| Mar 31, 2012 | 196,166.00 |
| Dec 31, 2011 | 53,377.00 |